(0.08%) 5 521.50 points
(0.13%) 39 894 points
(0.19%) 19 788 points
(-0.01%) $81.62
(0.60%) $2.83
(-0.29%) $2 337.50
(0.17%) $29.58
(0.27%) $1 004.50
(0.00%) $0.931
(-0.06%) $10.53
(-0.01%) $0.788
(-0.85%) $87.25
5.66% $ 0.237
Live Chart Being Loaded With Signals
Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for the treatment resistant cancers...
Stats | |
---|---|
Dzisiejszy wolumen | 313 195 |
Średni wolumen | 684 778 |
Kapitalizacja rynkowa | 4.17M |
EPS | $-0.110 ( Q3 | 2023-11-07 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.339 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0350 (19.34%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-15 | Milby Randy | Buy | 29 000 | Common Stock |
2023-11-30 | Milby Randy | Buy | 10 000 | Common Stock |
2023-11-07 | Bui Lynne A. | Buy | 25 000 | Options (right to buy) |
2023-11-07 | Appajosyula Sireesh | Buy | 25 000 | Options (right to buy) |
2023-11-07 | Anderson Kelly | Buy | 50 000 | Options (right to buy) |
INSIDER POWER |
---|
98.24 |
Last 99 transactions |
Buy: 3 498 545 | Sell: 667 792 |
Wolumen Korelacja
Hillstream BioPharma, Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Hillstream BioPharma, Korelacja - Waluta/Towar
Hillstream BioPharma, Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-7.14 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-7.14 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-0.750 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.196 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Hillstream BioPharma,
Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for the treatment resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-888, a dual Quatramer loaded IMCD inducer coupled with its anthracycline analogue for solid tumors; HSB-510, a targeted bifunctional inhibitory compound in Quatramer with single digit nanomolar IC50 against PI3K-delta and HDAC6, which is also known to downregulate; and HSB-114, an immunotherapeutic agent, which uses its Quatramer technology to deliver tumor necrosis factor-alpha gene into cancer cells. The company was incorporated in 2017 and is based in Bridgewater, New Jersey.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej